Stereochemical Identity of a Single Fluorosugar Enables Noninvasive Dual-Biomarker Fingerprinting of Cancer

Abstract Clinical molecular imaging of cancer largely relies on single biomarker-attributable readouts. Through an efficient trapping mechanism, 2-[18F]FDG robustly links PET readouts to the Warburg effect, illuminating only a single metabolic axis within the multichannel biochemical network of cancer. The versatile chemical space of synthetic fluorosugars, however, may offer an attractive framework for broadening the repertoire of metabolic markers accessible to noninvasive imaging. Here, we report Fluorine Metabolic Imaging (FMI), a molecular MRI strategy for simultaneous in vivo mapping of two metabolic biomarkers using a single probe. FMI exploits the altered biochemistry of 3-fluoro-3-deoxy-d-galactose (3FDGal), which undergoes orthogonal intracellular redox transformations mediated by ALDH1A1 and AKR1B1, each yielding a stably trapped fluorine-labeled metabolite with a characteristic 19F-NMR peak. Concurrently mapped by 19F-MRI, these two enzyme-attributable readouts enable noninvasive spatially resolved dual-biomarker visualization. We establish the trapping mechanism of 3FDGal and its enzymatic basis, demonstrating that 3FDGal-initiated fingerprints reflect dual-biomarker variations across different cancer cells. In vivo, FMI distinguishes tumors with contrasting metabolic phenotypes, herein demonstrated in human xenografts not detectable by the canonical 2-[18F]FDG-PET approach. Establishing this proof-of-concept platform for noninvasive multilayered tumor subtyping, FMI with fluorosugars extends metabolic imaging beyond the Warburg scheme into unexplored dimensions of cancer diagnostics.

Authors

Institutions

Publication Details

Journal
Journal of the American Chemical Society
Published
2026-11-17
DOI
https://doi.org/10.1021/jacs.6c16535
Primary Topic
Advanced NMR Techniques and Applications
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Stereochemical Identity of a Single Fluorosugar Enables Noninvasive Dual-Biomarker Fingerprinting of Cancer

Amnon Bar‐Shir, Hyla Allouche‐Arnon, Adam J. Shuhendler, Balamurugan Subramani et al.
2 links
Journal of the American Chemical Society
Advanced NMR Techniques and Applications
article

Stereochemical Identity of a Single Fluorosugar Enables Noninvasive Dual-Biomarker Fingerprinting of Cancer

Amnon Bar‐Shir, Hyla Allouche‐Arnon, Adam J. Shuhendler, Balamurugan Subramani, Claudia Kellner, Dan Cohen, Michal Fisler, Liat Avram, Dominic Graf, Yael Diskin‐Posner, Talia Harris, Clara S. Goulet, Shira Kutchinsky, Libi Saad, Alexander Brandis, Ariel Feler, Raz Z. Hayun, Silvia Carvalho
article en

Abstract

Abstract Clinical molecular imaging of cancer largely relies on single biomarker-attributable readouts. Through an efficient trapping mechanism, 2-[18F]FDG robustly links PET readouts to the Warburg effect, illuminating only a single metabolic axis within the multichannel biochemical network of cancer. The versatile chemical space of synthetic fluorosugars, however, may offer an attractive framework for broadening the repertoire of metabolic markers accessible to noninvasive imaging. Here, we report Fluorine Metabolic Imaging (FMI), a molecular MRI strategy for simultaneous in vivo mapping of two metabolic biomarkers using a single probe. FMI exploits the altered biochemistry of 3-fluoro-3-deoxy-d-galactose (3FDGal), which undergoes orthogonal intracellular redox transformations mediated by ALDH1A1 and AKR1B1, each yielding a stably trapped fluorine-labeled metabolite with a characteristic 19F-NMR peak. Concurrently mapped by 19F-MRI, these two enzyme-attributable readouts enable noninvasive spatially resolved dual-biomarker visualization. We establish the trapping mechanism of 3FDGal and its enzymatic basis, demonstrating that 3FDGal-initiated fingerprints reflect dual-biomarker variations across different cancer cells. In vivo, FMI distinguishes tumors with contrasting metabolic phenotypes, herein demonstrated in human xenografts not detectable by the canonical 2-[18F]FDG-PET approach. Establishing this proof-of-concept platform for noninvasive multilayered tumor subtyping, FMI with fluorosugars extends metabolic imaging beyond the Warburg scheme into unexplored dimensions of cancer diagnostics.

Journal of the American Chemical Society
University of Ottawa (CA), Ottawa Heart Institute (CA), Weizmann Institute of Science (IL)
Clore Israel Foundation, European Commission, German-Israeli Foundation for Scientific Research and Development, Israel Science Foundation
Good health and well-being
Advanced NMR Techniques and Applications
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon